TOTAL VOLUME:

$134.2b

24H VOL:

$130,522,377

24H TRANSACTIONS:

2,388,728,490

OPEN INTEREST:

$1,438,389,636

404,028

Markets across

30,214

events

MATCHED EVENTS:

2,681

PLATFORM COVERAGE:

5

Polymarket:

39%

VS.

Kalshi:

61%

BETA
Dashboards
Insights
Indices
Tour
All
Trending
Breaking
New
Ending Soon
Politics
Sports
Crypto
Companies
Elections
Financials
Economics
Other
Entertainment
Science and Technology
Counter-Strike: SkinRave vs Marsborne (BO3) - ESL Challenger League North America Cup 1 Playoffs
kalshi
polymarket

Counter-Strike: SkinRave vs Marsborne (BO3) - ESL Challenger League North America Cup 1 Playoffs

Volume:
$43,402

Marsborne

 - Kalshi

Marsborne - Kalshi

1W

News

Positive

Negative

Neutral

Hover marker for details

Vol.

·

Resolved Feb 23, 2026

Closed: Feb 23, 1:00 AM EST

kalshi

Kalshi

View
Join Kalshi and score $25 for your first trade.
Outcome
Trade
Chance %
Price
Spread
Liquidity
Volume
24h
7d
Open Interest
Ends in
Result
kalshi

Marsborne

View
100%
Yes 100¢No 0¢
—
N/A
$12,992
N/A
N/A
$8,910
Settled
Yes
kalshi

SkinRave

View
0%
Yes 0¢No 100¢
—
N/A
$13,021
N/A
N/A
$10,066
Settled
No
polymarket

Map Handicap: MARS (-1.5) vs SkinRave (+1.5)

100%
Yes 100¢No 0¢
—
N/A
$189
0%
N/A
N/A
N/A
polymarket

Match Winner

0%
Yes 0¢No 100¢
—
N/A
$9,005
0%
N/A
N/A
N/A
polymarket

Map 1 Winner

0%
Yes 0¢No 100¢
—
N/A
$5,104
0%
N/A
N/A
N/A
polymarket

Map 2 Winner

0%
Yes 0¢No 100¢
—
N/A
$2,950
0%
N/A
N/A
N/A
polymarket

O/U 2.5 Games

0%
Yes 0¢No 100¢
—
N/A
$140
0%
N/A
N/A
N/A
Total markets: 7

Description

This event group covers a Counter-Strike 2 best-of-three match between SkinRave and Marsborne in the ESL Challenger League North America Cup 1 Playoffs, scheduled for February 22, 2026 at 9:00 PM ET. Markets span match winner, map handicap, individual map outcomes, and series length, with resolution tied to official HLTV reporting.

PredictionHero - Resolution Divergence Alerts (RDA)

Divergence Detected

Issue: Kalshi's match winner market contains a logical contradiction: both possible outcomes (SkinRave wins OR Marsborne wins) are mapped to the same resolution (Yes), making the market fundamentally unresolvable. Polymarket provides coherent, granular resolution logic across all market types with explicit edge case handling.Hero tip: Disregard Kalshi's match winner market entirely due to logical impossibility. Trade only on Polymarket markets. For all Polymarket markets, note that forfeits/walkovers BEFORE match start resolve 50-50, but if the match begins and one team forfeits/is disqualified, that team's opponent wins. Map and handicap markets count forfeit maps toward totals if the overall match completes. Use HLTV.org as primary source; if results unavailable within 2 hours of conclusion, consensus of credible reporting (including video evidence) applies.

Critical divergence points:

  • Kalshi: Match winner market states: 'If SkinRave wins...then resolves to Yes' AND 'If Marsborne wins...then resolves to Yes'. This is a logical contradiction—both outcomes cannot both resolve to Yes in a binary market. The market is unresolvable as written.
  • Polymarket: Match winner resolves to team name (SkinRave or Marsborne) based on match outcome. Cancellations, ties, delays >7 days, and pre-match forfeits resolve 50-50. Mid-match forfeits/disqualifications resolve to the winning team. Map 1/2 markets resolve 50-50 if not completed. Handicap and total maps markets count forfeit maps if match completes; resolve 50-50 if match incomplete or pre-match forfeit. Primary source: HLTV.org; fallback to credible consensus within 2 hours.
Our PredictionHero Resolution Divergence Alerts (RDA) are there to help users identify potential differences across platforms. They do not replace or supersede the official rules and description of any prediction market. Users are solely responsible for reviewing and understanding the applicable rules and resolution criteria before placing any trade or bet. If you notice a potential inconsistency, discrepancy, or error in an alert, please report it to our team so we can review and improve the accuracy of our data.